Futura Medical PLC FUM Total Voting Rights

  Futura Medical PLC (FUM) - Total Voting Rights

RNS Number : 9649P
Futura Medical PLC
31 October 2012




For immediate release 31 October 2012

                                      

                                      

                              Futura Medical plc

                         ("Futura" or "the Company")

                                      

                             Total Voting Rights

Futura  Medical  plc  (AIM:  FUM),  the  pharmaceutical  group  that  develops 
innovative products for consumer healthcare, announces that, for the  purposes 
of the Disclosure  and Transparency  Rules, the Company's  total issued  share 
capital at the date of this announcement is 77,414,081 ordinary shares of 0.2p
each, with one voting right per share. There are no shares held in treasury.

The total number of voting rights in the Company is therefore 77,414,081.

The above  figure  of 77,414,081  shares  may be  used  by shareholders  as  a 
denominator for the  calculations by  which they  will determine  if they  are 
required to notify  their interest  in, or change  to their  interest in,  the 
Company, under the Disclosure and Transparency Rules.



For any further information please contact:



Futura Medical plc                                               
James Barder, Chief Executive             Tel: +44 (0)1483 685 670


mail to: james.barder@futuramedical.com      www.futuramedical.com
                                                                
Nomura Code Securities Limited                                   
Phil Walker / Giles Balleny                Tel:+44 (0)20 7776 1200
For media enquiries please contact:                              
                                                                
Buchanan Communications                                          
Mark Court / Fiona Henson / Sophie Cowles Tel: +44 (0)20 7466 5000





Notes to Editors



Futura Medical plc



Futura Medical is a pharmaceutical group that develops innovative products for
consumer healthcare. The Company is developing a portfolio of products and its
strategy  is  to   license  their  manufacture   and  distribution  to   major 
pharmaceutical and healthcare groups.



Futura is based in Guildford, Surrey, and  its shares trade on the AIM  market 
of the London Stock Exchange.

www.futuramedical.com

                     This information is provided by RNS
           The company news service from the London Stock Exchange

END


TVRFMMFGMMMGZZM -0- Oct/31/2012 11:33 GMT